Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: Evidence for a dopaminergic regulation of striatal nitric oxide release

[1]  R. Lenox,et al.  In vivo effects of pentobarbital and halothane anesthesia on levels of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in rat brain regions and pituitary. , 1980, Biochemical pharmacology.

[2]  S. Vincent,et al.  Striatal neurons containing both somatostatin‐ and avian pancreatic polypeptide (APP)‐like immunoreactivities and NADPH‐diaphorase activity: A light and electron microscopic study , 1983, The Journal of comparative neurology.

[3]  M. Ichikawa,et al.  Light and electron microscopic demonstration of guanylate cyclase in rat brain , 1983, Brain Research.

[4]  M. A. Ariano,et al.  Distribution of components of the guanosine 3′,5′-phosphate system in rat caudate-putamen , 1983, Neuroscience.

[5]  G. Graveland,et al.  Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.

[6]  S. Moncada,et al.  Bioassay of prostacyclin and endothelium‐derived relaxing factor (EDRF) from porcine aortic endothelial cells , 1997, British journal of pharmacology.

[7]  J. Hancock,et al.  The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. , 1987, The Biochemical journal.

[8]  B. Morris,et al.  Dopaminergic regulation of striatal proenkephalin mrna and prodynorphin mrna: Contrasting effects of d1 and d2 antagonists , 1988, Neuroscience.

[9]  J. Garthwaite,et al.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.

[10]  J. Garthwaite,et al.  NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. , 1989, European journal of pharmacology.

[11]  Richard Graham Knowles,et al.  Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Vincent,et al.  Histochemical characterization of neuronal NADPH-diaphorase. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  G Maura,et al.  Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release. , 1989, The Journal of pharmacology and experimental therapeutics.

[14]  Bruno Giros,et al.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.

[15]  C. Altar,et al.  Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP. , 1990, European journal of pharmacology.

[16]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[17]  L. Kerkérian,et al.  Cortical Regulation of Striatal Neuropeptide Y (NPY)‐Containing Neurons in the Rat , 1990, The European journal of neuroscience.

[18]  A. Graybiel Neurotransmitters and neuromodulators in the basal ganglia , 1990, Trends in Neurosciences.

[19]  D. Sibley,et al.  Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Philip Seeman,et al.  Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.

[21]  S. Hunt,et al.  Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists , 1991, Neuroscience Letters.

[22]  P. Conn Methods in neurosciences , 1991 .

[23]  S. Young,et al.  Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation , 1991, Brain Research.

[24]  S. Snyder,et al.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991, Nature.

[25]  Susan R. George,et al.  Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 , 1991, Nature.

[26]  J. Hancock,et al.  The use of diphenylene iodonium and its analogues to investigate the role of the NADPH oxidase in the tumoricidal activity of macrophages in vitro. , 1991, Free radical biology & medicine.

[27]  S. Vincent,et al.  Neuronal NADPH diaphorase is a nitric oxide synthase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Snyder,et al.  Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Garthwaite Glutamate, nitric oxide and cell-cell signalling in the nervous system , 1991, Trends in Neurosciences.

[30]  F. Murad,et al.  Purification and characterization of a human NO synthase. , 1991, Biochemical and biophysical research communications.

[31]  G. Böhme,et al.  Possible involvement of nitric oxide in long-term potentiation. , 1991, European journal of pharmacology.

[32]  S. Young,et al.  Terminal excitability of the corticostrial pathway. I. Regulation by dopamine receptor stimulation , 1991, Brain Research.

[33]  C. Nathan,et al.  Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  J. Garthwaite,et al.  NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway , 1991, Neuroscience Letters.

[35]  F. Murad,et al.  Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[36]  B. Morris Neuropeptide Y Gene Expression , 1992 .

[37]  B. Yamamoto,et al.  Dopaminergic Modulation of Glutamate Release in Striatum as Measured by Microdialysis , 1992, Journal of neurochemistry.

[38]  D. Okada Two Pathways of Cyclic GMP Production Through Glutamate Receptor‐Mediated Nitric Oxide Synthesis , 1992, Journal of neurochemistry.

[39]  D. Reis,et al.  Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. N. Wallace,et al.  Activated astrocytes of the mouse hippocampus contain high levels of NADPH-diaphorase. , 1992, Neuroreport.

[41]  P. Klatt,et al.  Ca2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. , 1992, The Journal of biological chemistry.

[42]  G. Wolf,et al.  Nitric oxide synthase in rat brain is predominantly located at neuronal endoplasmic reticulum: an electron microscopic demonstration of NADPH-diaphorase activity , 1992, Neuroscience Letters.

[43]  P. Marin,et al.  A Nitric Oxide Synthase Activity Selectively Stimulated by NMDA Receptors Depends on Protein Kinase C Activation in Mouse Striatal Neurons , 1992, The European journal of neuroscience.

[44]  B. Ziółkowska,et al.  The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum , 1993, Neuroscience Letters.

[45]  Joseph Loscalzo,et al.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds , 1993, Nature.

[46]  R. Mackenzie,et al.  Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization. , 1993, Molecular pharmacology.

[47]  P. Marin,et al.  Non-classical glutamate receptors, blocked by both NMDA and non-NMDA antagonists, stimulate nitric oxide production in neurons , 1993, Neuropharmacology.

[48]  Takahiro Matsumoto,et al.  A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative , 1993, Neuroscience Letters.

[49]  Yongxiang Wang,et al.  Inhibitory actions of diphenyleneiodonium on endothelium‐dependent vasodilatations in vitro and in vivo , 1993, British journal of pharmacology.

[50]  H. Johnston,et al.  Coexistence of NADPH diaphorase with GABA, glycine, and acetylcholine in rat spinal cord , 1993, The Journal of comparative neurology.

[51]  D. Ingram,et al.  The correlation between neuron counts and optical density of NADPH-diaphorase histochemistry in the rat striatum: a quantitative study , 1994, Brain Research.

[52]  R. Traub,et al.  Spinal cord NADPH-diaphorase histochemical staining but not nitric oxide synthase immunoreactivity increases following carrageenan-produced hindpaw inflammation in the rat , 1994, Brain Research.

[53]  H. Schulman,et al.  Nitric oxide stimulates Ca2+-independent synaptic vesicle release , 1994, Neuron.

[54]  R. Weinberg,et al.  Type I nitric oxide synthase fully accounts for nadph-diaphorase in rat striatum, but not cortex , 1994, Neuroscience.

[55]  S. D. Meriney,et al.  Somatostatin-induced inhibition of neuronal Ca2+ current modulated by cGMP-dependent protein kinase , 1994, Nature.

[56]  B. Morris,et al.  Phenotypic characterisation of rat striatal neurones in primary culture. , 1994, Tissue & cell.

[57]  NADPH diaphorase-positive cells in the brain after status epilepticus. , 1994, Neuroreport.

[58]  B. Morris,et al.  Modulation of α‐Amino‐3‐Hydroxy‐5‐Methylisoxazole‐4‐Propionic Acid (AMPA) Binding Sites by Nitric Oxide , 1994, Journal of neurochemistry.

[59]  E. Kandel,et al.  Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation , 1994, Nature.

[60]  M. Marletta,et al.  Nitric oxide synthase: Aspects concerning structure and catalysis , 1994, Cell.

[61]  H. Johnston,et al.  NMDA and Nitric Oxide Increase Microtubule‐Associated Protein 2 Gene Expression in Hippocampal Granule Cells , 1994, Journal of neurochemistry.

[62]  Yong Liu,et al.  Induction of NADPH-diaphorase activity in the hippocampus in a rat model of cerebral ischemia and ischemic tolerance , 1994, Brain Research.

[63]  B. Morris,et al.  Nitric oxide alters proenkephalin and prodynorphin gene expression in hippocampal granule cells , 1994, Neuroscience.

[64]  W. Schmidt,et al.  Evidence for bidirectional changes in nitric oxide synthase activity in the rat striatum after excitotoxically (quinolinic acid) induced degeneration , 1995, Neuroscience.

[65]  Shigetada Nakanishi,et al.  Second-order neurones and receptor mechanisms in visual- and olfactory-information processing , 1995, Trends in Neurosciences.

[66]  K. Nozaki,et al.  Ultrastructural localization and translocation of nitric oxide synthase in the endothelium of the human cerebral artery , 1995, Brain Research.

[67]  B. Morris,et al.  Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C , 1995, Neuroscience.

[68]  A. Morton,et al.  Correlation of neuronal loss with increased expression of NADPH diaphorase in cultured rat cerebellum and cerebral cortex , 1995, Brain Research.

[69]  B. Morris Stimulation of immediate early gene expression in striatal neurons by nitric oxide. , 1995, The Journal of biological chemistry.

[70]  P. Slater,et al.  Localization of neuronal and endothelial nitric oxide synthase isoforms in human hippocampus , 1997, Neuroscience.